Zepbound KwikPen, a 4-dose single-patient delivery device for tirzepatide administration has been made available by Lilly.
Nutrition and lifestyle interventions, including whole-food plant-based diets, show promise in managing mood disorders and ...
Metabolic syndrome exacerbates inpatients outcomes and increased health care use among patients hospitalized with IBD.
Colorectal cancer was more common among patients with inflammatory bowel disease who had high-grade dysplasia.
The FDA proposed new guidelines for approving experimental therapies for rare diseases without large group studies.
Ralph Abraham, the deputy secretary general of the CDC, stepped down effective immediately on Monday, February 23.
FDA approves swallowable Allurion Gastric Balloon for weight loss in adults with obesity who failed prior lifestyle programs.
Novo Nordisk has pledged to cut US list prices of Ozempic and Wegovy to about $675 per month starting January 1, 2027.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results